Clozyl is a penicillinase-resistant antibacterial medicine belonging to the beta-lactam antibiotic class, widely used for the effective treatment of Gram-positive bacterial infections. It is specifically designed to combat infections caused by penicillinase-producing Staphylococci, helping to control bacteria that are resistant to many standard antibiotics. This medicine is indicated for a broad range of bacterial conditions, including skin and soft tissue infections, respiratory tract infections, bone and joint infections, and other systemic infections caused by susceptible organisms. Clozyl plays an important role in targeted antibacterial therapy by inhibiting bacterial cell wall synthesis, thereby stopping bacterial growth and spread. It is commonly used in clinical practice to manage both mild and severe bacterial infections under medical supervision.